Normal
Attend a special investor briefing with Steven Yatomi-Clarke, CEO and MD of Prescient Therapeutics (PTX), this Wednesday, 21 September at 12pm AEST to find out more about their revolutionary cell therapy CAR-T and the company's flagship technology OmniCAR.Book your spot here: https://bit.ly/3Ud7Mad
Attend a special investor briefing with Steven Yatomi-Clarke, CEO and MD of Prescient Therapeutics (PTX), this Wednesday, 21 September at 12pm AEST to find out more about their revolutionary cell therapy CAR-T and the company's flagship technology OmniCAR.
Book your spot here: https://bit.ly/3Ud7Mad
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.
